This test is most useful if any of these apply to you.
A single amylase result can send people down the wrong path. Amylase is a digestive enzyme, and a high level is often read as a warning about the pancreas. But your salivary glands make nearly the same enzyme and release just as much of it into your blood.
This panel splits that one number into its two sources. When a total amylase comes back high and nobody can explain why, knowing whether the extra amylase is pancreatic or salivary is what turns a puzzling result into a clear next step. It is a targeted test for a specific question, not a routine screen.
Total amylase is the sum of everything. It tells you the level is high but not why, and up to 60% of the amylase in your blood comes from tissues other than the pancreas. That mismatch is the exact limitation this panel is built to correct.
Pancreatic amylase (often called the P-type fraction) measures the share made by your pancreas. Salivary amylase (the S-type fraction) measures the share from your salivary glands and a few other tissues. Measured side by side against the total, they reveal which source is doing the work.
In healthy blood the two fractions sit in a fairly steady balance, with most everyday amylase actually coming from the salivary side. Disease tips that balance. A pancreas under stress pushes the pancreatic fraction up, while salivary gland problems and many unrelated conditions push the salivary fraction up instead.
The value of this panel is in the comparison, not any single number. The pattern between the pancreatic and salivary fractions is what points you toward or away from the pancreas.
| Pattern | What It Suggests |
|---|---|
| High total amylase, pancreatic fraction predominant | Points to the pancreas, such as pancreatitis or gallstone-related involvement. Confirm with a lipase test and imaging. |
| High total amylase, salivary fraction predominant | Points away from the pancreas, toward salivary glands, some tumors, or metabolic and post-surgical states. |
| Persistently high total amylase, normal lipase, low urine amylase | Suggests macroamylasemia, a harmless clearance quirk rather than pancreatic disease. |
| Normal total amylase with strong symptoms | Does not rule out the pancreas; the pancreatic fraction can stay elevated after the total has settled. |
A pancreatic-predominant result alongside abdominal pain is worth taking to a clinician promptly. Acute pancreatitis is generally confirmed when two of three things line up: typical pain, an enzyme level at or above three times the upper limit of normal (the top of the standard range), and characteristic imaging. In practice, lipase and a scan usually settle the question.
A salivary-predominant result redirects the search toward salivary glands, certain medications, heavy alcohol use, or other non-pancreatic causes. A persistently high total with normal lipase and low urine amylase raises the possibility of macroamylasemia, which is benign but needs a urine or clearance test to confirm.
This is not a tracking tool. Once a diagnosis is made, repeating enzyme levels day after day adds little, so reorder mainly to confirm an odd result or when a new, unexplained elevation appears. For most people with clear-cut, obvious pancreatitis, lipase alone answers the question, and this panel earns its place in the harder, uncertain cases.
Timing shapes everything. In a pancreatic attack, amylase rises within about 6 to 24 hours, peaks near 48 hours, and can fall back to normal within a few days, so testing late can look falsely reassuring. Helpfully, the pancreatic fraction often stays abnormal longer than the total, which is where fractionation earns its keep.
Reduced kidney clearance can raise amylase with no pancreatic problem at all, and a small number of healthy people have a harmless, long-standing elevation of pancreatic enzymes with no identifiable disease behind it. Because of this, current guidance treats lipase as the preferred first enzyme for suspected pancreatitis. In pooled studies at three times the upper limit of normal, lipase caught roughly 80% of cases and correctly cleared about 93% of people without the disease, while amylase caught about 71% but was slightly more specific at 99%. This panel is best used as an adjunct when the simpler tests leave real doubt.
Amylase Isoenzymes is best interpreted alongside these tests.